Updated Jul 16, 2026
Nayak Sanjay has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $162K.

| Role | Chief Strategy Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-28 | OCUL | OCULAR THERAPEUTIX, INC | S — Open-market sale | 1.9K | $8.20 | $15K |
| 2026-02-25 | OCUL | OCULAR THERAPEUTIX, INC | S — Open-market sale | 1.8K | $8.28 | $15K |
| 2026-02-18 | OCUL | OCULAR THERAPEUTIX, INC | S — Open-market sale | 10.3K | $9.04 | $94K |
| 2025-08-25 | OCUL | OCULAR THERAPEUTIX, INC | S — Open-market sale | 1.9K | $12.04 | $23K |
| 2024-11-27 | OCUL | OCULAR THERAPEUTIX, INC | S — Open-market sale | 1.8K | $9.00 | $16K |
Nayak Sanjay is a corporate insider — currently tracked as Chief Strategy Officer of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($162K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Nayak Sanjay profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.